← Back to Search

Behavioural Intervention

Neural Operant Conditioning for Stroke-Related Walking Difficulties

N/A
Recruiting
Led By James Sulzer, PhD
Research Sponsored by MetroHealth Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Unilateral hemiparesis of the lower limbs
At least 3 months since stroke event
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 6 -mid-treatment, week 12 - end of treatment, 4-week post treatment, 12 weeks post treatment, 24 weeks post treatment
Awards & highlights

Study Summary

This trial is testing if operant conditioning can reduce spasticity in stroke patients, allowing them to improve walking. Participants will be asked to control spinal reflexes to reduce spasticity and researchers will compare results to able-bodied people.

Who is the study for?
This trial is for adults over 18 who had a stroke at least 3 months ago, can stand and walk for five minutes, and had independent mobility before their stroke. They should have reduced knee flexion when walking and be able to respond to nerve stimulation. People with severe cognitive issues, lower limb pain or injuries, certain neurological conditions other than stroke, uncontrolled seizures, or those pregnant cannot participate.Check my eligibility
What is being tested?
The study tests if operant conditioning with peripheral nerve stimulation can help stroke patients control spinal reflexes to reduce spasticity and improve walking. Participants' results will be compared with those of able-bodied individuals to assess the effectiveness of this technique.See study design
What are the potential side effects?
Potential side effects may include discomfort from the stimulation device, skin irritation where it's applied, muscle fatigue due to repeated use during sessions, and possible mild pain or soreness after treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have weakness on one side of my lower body.
Select...
It has been over 3 months since my stroke.
Select...
I can stand and walk for at least 5 minutes without help.
Select...
My knee doesn't bend as much as the other when I walk.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 6 -mid-treatment, week 12 - end of treatment, 4-week post treatment, 12 weeks post treatment, 24 weeks post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 6 -mid-treatment, week 12 - end of treatment, 4-week post treatment, 12 weeks post treatment, 24 weeks post treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Surface electromyographic recording of leg muscles
Secondary outcome measures
10 meter walk test
Five Times Sit to Stand Test
TMS
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental: Post-stroke Stiff-Knee Gait ParticipantsExperimental Treatment1 Intervention
Individuals with post-stroke Stiff-Knee gait

Find a Location

Who is running the clinical trial?

MetroHealth Medical CenterLead Sponsor
114 Previous Clinical Trials
21,329 Total Patients Enrolled
16 Trials studying Stroke
899 Patients Enrolled for Stroke
James Sulzer, PhDPrincipal InvestigatorMetroHealth Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many volunteers have enrolled in this clinical trial?

"Yes, clinicaltrials.gov provides evidence that this medical study is currently recruiting participants. It was first announced on May 31st 2024 and the details were updated most recently on October 27th 2023. The trial requires a total of 60 volunteers from 1 site to participate."

Answered by AI

Are recruitment efforts still underway for this trial?

"Correct, a review of the clinicaltrials.gov website reveals that this medical trial is still recruiting participants as of October 27th 2023. This study commenced on May 31st 2024 and is targeting 60 patients from one centre."

Answered by AI
~40 spots leftby May 2027